Skip to content
Search

Latest Stories

UK launches £7.5m trial to tackle low Covid vaccine take-up in pregnant women

UK launches £7.5m trial to tackle low Covid vaccine take-up in pregnant women

PREGNANT women are more likely to become seriously ill from Covid-19 and should get themselves vaccinated, department of health and social care said today (3) while announcing the launch of England’s largest clinical trial  to figure out the best interval time between the two doses of Covid-19 for pregnant women.

The Preg-CoV study, backed by £7.5 million of government funding and led by St George’s, University of London, will provide vital clinical trial data on the immune response at different dose intervals - either four to six weeks or eight to 12 weeks, the department said, adding that the study will help determine the best dosage interval.


The trial will be run across 13 National Institute for Health Research (NIHR) sites in England - including in London, Liverpool and Leeds. All the trial sites are working on ways of including participants from a wide variety of backgrounds and individuals from ethnic minorities are encouraged to apply.

Involving data of 600 pregnant women being vaccinated with either the Pfizer/BioNTech or the Moderna vaccine, the trial will closely monitor the health of pregnant women throughout their pregnancy and following the birth.

The announcement comes after it emerged that most of the pregnant women in the country are still unvaccinated. Following 130,000 pregnant women being vaccinated in the US and no safety concerns being raised, vaccines were recommended by the independent experts at the Joint Committee on Vaccination and Immunisation (JCVI) for pregnant women in the UK back in April.

However, vaccine take-up in pregnant women is still less and has recently been a matter of concern among the experts.

Data published last week by NHS England and the University of Oxford also shows no pregnant women who have had both doses of a vaccine have been admitted to hospital with Covid-19 while 98 per cent pregnant mums admitted to hospital have not received a jab.

Calling eligible expecting mothers to sign-up for the trial, vaccine minister Nadhim Zahawi said: “Pregnant women are more likely to get seriously ill from COVID-19 and we know that vaccines are safe for them and make a huge difference – in fact no pregnant woman with two jabs has required hospitalisation with COVID-19.

“This government-backed trial will provide more data about how we can best protect pregnant women and their babies, and we can use this evidence to inform future vaccination programmes,” Zahawi said.

Further analysis from PHE and the University of Cambridge also suggests vaccines have so far prevented over 52,600 hospitalisations, an estimated 22 million infections and more than 60,000 deaths in England alone.

Volunteers can sign up to the trial here: https://vaccine.ac.uk/research/preg-cov-trial/

More For You

Liz Kendall

Work and pensions secretary Liz Kendall will outline welfare reforms in a green paper next week, followed by chancellor Rachel Reeves’ Spring Statement on 26 March.

Ministers may drop plan to freeze disability benefits: Report

MINISTERS are considering dropping plans to freeze Personal Independence Payments (PIP) for a year, according to a report.

Initial proposals suggested PIP would not rise in line with inflation, but strong opposition from Labour MPs has prompted a review.

Keep ReadingShow less
BBC settles age and sex discrimination case
BBC headquarters in Central London.
Getty Images

BBC settles age and sex discrimination case

THE BBC on Friday (14) said it had settled a case with four female journalists who claimed they lost their jobs because of their sex and age.

Martine Croxall, Annita McVeigh, Karin Giannone and Kasia Madera, who have all presented on the BBC's television channels, claimed they lost their jobs following a "rigged" recruitment exercise.

Keep ReadingShow less
Indian student in US self-deports after visa revocation

In this screenshot from a video posted by @Sec_Noem via X on March 14, 2025, Ranjani Srinivasan, an Indian citizen who participated in pro-Palestinian protests at United State’s Columbia University, leaves the country after her visa was revoked by the Department of State. (@Sec_Noem via PTI Photo)

Indian student in US self-deports after visa revocation

AN INDIAN student at Columbia University, whose visa was revoked for allegedly supporting Hamas, has self-deported, says the Department of Homeland Security (DHS).

Ranjani Srinivasan, an Indian citizen, came to the US on an F-1 student visa as a doctoral student in Urban Planning at Columbia University, and her visa was revoked on March 5.

Keep ReadingShow less
'Companies with diverse leadership are better positioned for growth'

From LtoR- Lord Karan Bilimoria, Sir Trevor Phillips, Seema Malhotra MP, David Tyler and Nathan Coe

'Companies with diverse leadership are better positioned for growth'

COMPANIES with diverse leadership are better positioned for sustainable growth, improved decision-making, and will connect better with multicultural markets, equalities minister Seema Malhotra has said.

She added that the government will soon launch a public consultation on their approach to mandatory ethnicity and disability pay gap reporting.

Keep ReadingShow less
Subrahmanyam Jaishankar with  Wang Yi (right)

Subrahmanyam Jaishankar with Wang Yi (right)

S Jaishankar: ‘Delhi’s global interests shape its regional ties'

INDIA today sees itself as a global power or, at least, a country with global interests, which is why Subrahmanyam Jaishankar has spoken of its equation with Russia, China and notably the Middle East.

India’s external affairs minister was in conversation last Wednesday (5) in London with Bronwen Maddox, director of the Royal Institute of International Affairs at Chatham House.

Keep ReadingShow less